Logo
x

Search category

Subscribe Now

rare disease portfolio

PTC Therapeutics to Acquire Censa Pharmaceuticals to Bolster its Rare Disease Portfolio

PTC Therapeutics to Acquire Censa Pharmaceuticals to Bolster its Rare Disease Portfolio

  • May 7, 2020
Therachon Acquires GLyPharma Therapeutic to Expand its Rare Disease Portfolio

Therachon Acquires GLyPharma Therapeutic to Expand its Rare Disease Portfolio

  • October 10, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.